G

GemPharmatech Co Ltd
SSE:688046

Watchlist Manager
GemPharmatech Co Ltd
SSE:688046
Watchlist
Price: 15.14 CNY 3.56% Market Closed
Market Cap: 6.2B CNY

Wall Street
Price Targets

Price Targets Summary
GemPharmatech Co Ltd

There are no price targets for GemPharmatech Co Ltd.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
GemPharmatech Co Ltd Competitors:
Price Targets
301333
R&G PharmaStudies Co Ltd
25% Upside
603127
Joinn Laboratories China Co Ltd
30% Downside
DIM
Sartorius Stedim Biotech SA
25% Upside
LAB
Standard BioTools Inc
95% Upside
DIVISLAB
Divi's Laboratories Ltd
8% Downside
AZTA
Azenta Inc
22% Upside
237690
ST Pharm Co Ltd
31% Upside
EVT
Evotec SE
39% Upside

Revenue
Forecast

Revenue Estimate
GemPharmatech Co Ltd

For the last 5 years the compound annual growth rate for GemPharmatech Co Ltd's revenue is 29%. The projected CAGR for the next 2 years is 15%.

29%
Past Growth
15%
Estimated Growth
Estimates Accuracy
-3%
Average Miss

Operating Income
Forecast

Operating Income Estimate
GemPharmatech Co Ltd

For the last 5 years the compound annual growth rate for GemPharmatech Co Ltd's operating income is 17%. The projected CAGR for the next 3 years is 25%.

17%
Past Growth
25%
Estimated Growth
Estimates Accuracy
-12%
Average Miss

Net Income
Forecast

Net Income Estimate
GemPharmatech Co Ltd

For the last 5 years the compound annual growth rate for GemPharmatech Co Ltd's net income is 26%. The projected CAGR for the next 2 years is 41%.

26%
Past Growth
41%
Estimated Growth
Estimates Accuracy
-13%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is GemPharmatech Co Ltd's stock price target?
Not Available

GemPharmatech Co Ltd doesn't have any price targets made by Wall Street professionals.

What is GemPharmatech Co Ltd's Revenue forecast?
Projected CAGR
15%

For the last 5 years the compound annual growth rate for GemPharmatech Co Ltd's revenue is 29%. The projected CAGR for the next 2 years is 15%.

What is GemPharmatech Co Ltd's Operating Income forecast?
Projected CAGR
25%

For the last 5 years the compound annual growth rate for GemPharmatech Co Ltd's operating income is 17%. The projected CAGR for the next 3 years is 25%.

What is GemPharmatech Co Ltd's Net Income forecast?
Projected CAGR
41%

For the last 5 years the compound annual growth rate for GemPharmatech Co Ltd's net income is 26%. The projected CAGR for the next 2 years is 41%.

Back to Top